These effects, along with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two guidance the strategy of targeting ACKR3 as a novel technique to modulate the opioid process, which could open up new therapeutic avenues for opioid-associated disorders. Dependant on readily available science https://cullenv554rfb5.wikigiogio.com/user